10% Spectinomycin sulphate+5% Linomycin HCL injection

COMPOSITION

Each ml contains:

Spectinomycin(Sulphate)…100mg

Lincomycin (HCI)…50 mg

PHARMACEUTICAL FORM:

Solution Injection

DESCRIPTION

The combination of lincomycin and spectinomycin acts additive and in some cases synergistic.

Spectinomycin acts bacteriostatic or bactericidal depending on the dose, against mainly Gram-negative bacteria like Campylobacter, E. coli and Salmonella spp. Lincomycin acts bacteriostatic against mainly Gram-positive bacteria like Mycoplasma, Treponema, staphylococcus and Streptococcus spp. Cross-resistance of lincomycin with macrolides can occur

INDICATIONS

Gastrointestinal and respiratory infections caused by lincomycin and spectinomycin sensitive micro-organisms, like Campylobacter, E. coli, Mycoplasma, Salmonella Staphylococcus, Streptococcus and Treponema spp. in calves, goats, sheep, dogs and cats.

MODE OF ADMINISTRATION

By intramuscular injection

DOSAGE:

Calves:  1 ml per 10 kg body weight for 4 days.

Goats and sheep:  ml per 10 kg body weight for 3 days.

Cats and dogs:  1 ml per 5 kg body weight for 3-5 days, with a maximum of 21 days.

WITHDRAWAL PERIOD

Calves, goats and sheep

For meat:  14 days.

For milk:  3 days.

CONTRAINDICATIONS

Hypersensitivity to lincomycin and/ or spectinomycin

Administration to animals with an impaired renal and/ or hepatic function

Concurrent administration of penicillins, cephalosporins, quinolones and

cycloserine.

SIDE EFFECTS

Hypersensitivity reactions.

Shortly after injection a slight pain, itching or diarrhoea can occur

STORAGE:

Protect from direct sunlight and store below 30℃

Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 11 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own- label preparations, and OEM & ODM service.

Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.

Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific management. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.